Search

everythinglearnresearchcommunity

for

Search:↓

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Body hair can be used as an extra source of donor hair in hair restoration surgery for people with severe hair loss.

Carlos Oscar Uebel developed a hair transplant method that looks natural, has low risk, and shows full growth in 6-12 months.

Follicular Unit Extraction (FUE) is a less invasive hair transplant method with minimal scarring, suitable for about 60% of patients, especially those needing fewer grafts and quicker recovery.

Children's hair grows in different types from before birth through puberty, with growth rates and characteristics varying by age, sex, and race.

New techniques in hair restoration surgery can fix unnatural results from old methods, improving patient self-esteem.

FUE is a less invasive hair transplant method suitable for many patients, but it has limitations and may not replace traditional techniques.

Using bacitracin zinc and selenium sulfide one after the other can temporarily turn white hair yellow.

Dr. Umar successfully used softer hair from the nape and around the ear for natural-looking hairlines in 128 patients, with some concerns about hair loss over time.

Densitometry and video-microscopy are precise for evaluating hair loss and transplant success but need special equipment and training.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Finasteride effectively treats frontal hair loss with few side effects.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Hydroxychloroquine effectively reduces symptoms of frontal fibrosing alopecia, especially in the first 6 months.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

FFA's causes may include environmental triggers and genetic factors.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Hair transplant destroyed by lichen planopilaris.